Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.

Authors :: Naqash, Abdul Rafeh
Ricciuti, Biagio
Owen, Dwight H.
Florou, Vaia
Toi, Yukihiro
Cherry, Cynthia
Hafiz, Maida
De Giglio, Andrea
Muzaffar, Mavish
Patel, Sandip H.
Sugawara, Shunichi
Burkart, Jarred
Park, Wungki
Chiari, Rita
Sugisaka, Jun
Otterson, Gregory A.
de Lima Lopes, Gilberto
Walker, Paul R.
Source :: Cancer Immunology, Immunotherapy. Jul2020, Vol. 69 Issue 7, p1189-1189. 1p.
Publication Year :: 2020
Abstract: The original version of this article unfortunately contained a mistake. The second sentence of the section "irAEs and ICI efficacy" should read as. [ABSTRACT FROM AUTHOR]

Subjects :: *NON-small-cell lung carcinoma
*GLOBAL analysis (Mathematics)
*ADVERSE health care events

Full Text Access

Tools